(Q43631385)

25 November 2017

title

Changes in lymphocyte subpopulations in patients treated with cefodizime for acute lower respiratory tract infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1526680

5 October 2022

author name string

Y. Valcke

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1526680

5 October 2022

M. Van der Straeten

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1526680

5 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1526680

5 October 2022

publication date

1 January 1992

1 reference

25 November 2017

1 reference

25 November 2017

volume

20 Suppl 1

1 reference

25 November 2017

page(s)

S58-60

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01709955

25 November 2017

exact match

0 references

cites work

Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia

1 reference

12 December 2020

In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime

1 reference

12 December 2020

Effects of cefodizime on non-specific immune functions in patients with multiple myeloma

1 reference

12 December 2020

Lung defense mechanisms (first of two parts)

1 reference

12 December 2020

Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure.

1 reference

12 December 2020

Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01709955

1 reference

25 November 2017

1 reference